http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1513110-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b3a84ce1bda750fe5a70cfb1d62ebc2
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-673
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C45-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-71
filingDate 1976-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1513110-A
titleOfInvention Therapeutically active phenylethanolamine derivatives
abstract 1513110 Phenylalkanoylamines LES LABORATOIRES BRUNEAU & CIE 19 Oct 1976 [22 Oct 1975] 43348/76 Heading C2C Compounds of the general Formula (I) (Z = C 2-4 hydroxyalkyl, C 3-4 dihydroxyalkyl; R = H, C 1-6 alkyl; R 1 = H, C 1-6 alkyl, C 3-6 cycloalkyl, R 2 R 3 R 4 PhC x H 2x ; x = 2-5; R 2-4 = H, OH, OMe, OEt or two in adjacent positions = O(CH 2 ) 1 , 2 O) and their salts and N- benzyl and dibenzyl (R 1 = H) derivatives are prepared by brominating a compound of the Formula (II) (Z<SP>1</SP> = acylated Z; Ac = acyl, benzyl), condensing the α-bromoketone obtained with the appropriate primary amine or its benzyl derivative or dibenzylamine, in any order removing the protecting groups and reducing the CO group to CHOH, if desired reductively alkylating a resulting primary amine, effecting isomer separation and/or converting the product to a salt. The preparation of the starting materials of Formula (II), the corresponding compounds in which the phenolic hydroxy group and/or the hydroxy group(s) in the side chain are not protected o - (2 - acetoxyethoxy)phenyl acetate and o - (2 - propionoxyethoxy)phenyl propionate is described. The compounds of Formula (I) and their salts are bronchospasmolytics, and may be administered in the form of pharmaceutical preparations containing them in association with a carrier.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0052963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4382958-A
priorityDate 1975-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419509663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410490416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154170124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432105351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92007240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432133441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401

Total number of triples: 34.